Experimental vaccine fails to protect babies against TB

02/4/2013 | Medical News Today

The MVA85A vaccine has been developed to boost the immune responses of the Bacille Calmette-Guérin vaccine against tuberculosis, but a trial in South Africa found that the experimental vaccine was not as effective in babies as it has been shown to be in adults. The vaccine's efficacy rate of 17.3% was not statistically significant, researchers reported in The Lancet.

View Full Article in:

Medical News Today

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD